Skye Bioscience, Inc. (SKYE)

0.7204 -0.02 (-2.38%) USD  |  NASDAQ  |  Mar 06, 16:00
0.7345 +0.01 (+1.96%) After-Hours: 20:00
More

Skye Bioscience SG&A Expense (TTM) : 16.93M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. 207.09M
Merck & Co., Inc. 10.73B
ACADIA Pharmaceuticals, Inc. 548.89M
Alnylam Pharmaceuticals, Inc. 1.211B
Savara, Inc. 37.38M